Sanofi is building its own AI ecosystem to give the French pharma giant an edge - Fortune

Sanofi is building its own AI ecosystem to give the French pharma giant an edge  Fortune

Sanofi Rare Disease Pipeline Progress Puts Recent Share Price Weakness In Focus - Yahoo Finance

Sanofi Rare Disease Pipeline Progress Puts Recent Share Price Weakness In Focus  Yahoo Finance

Sanofi’s Venglustat Granted Priority Review By The FDA For Treatment Of GD3 (May 28) - TradingView

Sanofi’s Venglustat Granted Priority Review By The FDA For Treatment Of GD3 (May 28)  TradingView

FDA grants priority review for Sanofi’s venglustat NDA - Pharmaceutical Business review -

FDA grants priority review for Sanofi’s venglustat NDA  Pharmaceutical Business review -

Andrea Michael Meyer, Sanofi: Collaboration is an Imperative - Supply Chain Digital

Andrea Michael Meyer, Sanofi: Collaboration is an Imperative  Supply Chain Digital

November date set for FDA decision on Sanofi's Gaucher drug - pharmaphorum

November date set for FDA decision on Sanofi's Gaucher drug  pharmaphorum

Sanofi’s venglustat accepted for priority review by FDA - The Pharma Letter

Sanofi’s venglustat accepted for priority review by FDA  The Pharma Letter

ATS 2026: Mixed results for Sanofi/Regeneron’s itepekimab cloud COPD prospects - Clinical Trials ...

ATS 2026: Mixed results for Sanofi/Regeneron’s itepekimab cloud COPD prospects  Clinical Trials Arena

Sanofi (NASDAQ: SNY) posts strong phase 2 AATD data for efdoralprin alfa - Stock Titan

Sanofi (NASDAQ: SNY) posts strong phase 2 AATD data for efdoralprin alfa  Stock Titan

Compass Pathways Adds Former Sanofi and Cerevel Executive Kathleen Tregoning to Board - citybiz

Compass Pathways Adds Former Sanofi and Cerevel Executive Kathleen Tregoning to Board  citybiz

Sanofi launches AI-powered rare disease pre-diagnosis tool in India - BioSpectrum India

Sanofi launches AI-powered rare disease pre-diagnosis tool in India  BioSpectrum India

Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered...

Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review  statnews.com

Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report - Fierce Pharma

Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report  Fierce Pharma

Sanofi requests removal of Tzield from CNPV program after Høeg gets involved - BioSpace

Sanofi requests removal of Tzield from CNPV program after Høeg gets involved  BioSpace

Sanofi (SNY) Receives FDA Priority Review for Venglustat Applica - GuruFocus

Sanofi (SNY) Receives FDA Priority Review for Venglustat Applica  GuruFocus

Sanofi asks to pull diabetes drug out of FDA voucher program, STAT News reports - Reuters

Sanofi asks to pull diabetes drug out of FDA voucher program, STAT News reports  Reuters

Sanofi expands AI capabilities, investing $294M to scale Toronto hub - Fierce Pharma

Sanofi expands AI capabilities, investing $294M to scale Toronto hub  Fierce Pharma

Pharmalittle: We're reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more...

Pharmalittle: We're reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more  statnews.com

Sanofi says rare lung disease drug outperforms standard care in trial - Reuters

Sanofi says rare lung disease drug outperforms standard care in trial  Reuters

Sanofi: Information concerning the total number of voting rights and shares - April 2026 - Yahoo ...

Sanofi: Information concerning the total number of voting rights and shares - April 2026  Yahoo Finance

The human change challenge: How Sanofi gets workforce buy-in for AI - imd.org

The human change challenge: How Sanofi gets workforce buy-in for AI  imd.org

Sanofi invests $294M to expand AI Center of Excellence in Toronto and accelerate innovation for p...

Sanofi invests $294M to expand AI Center of Excellence in Toronto and accelerate innovation for patients  Yahoo Finance

Four Penn State researchers receive iDEA-TECH awards from Sanofi - Penn State Health News

Four Penn State researchers receive iDEA-TECH awards from Sanofi  Penn State Health News

Sanofi research priorities in flux as new CEO logs in - statnews.com

Sanofi research priorities in flux as new CEO logs in  statnews.com

A Million Conversations: Bridging Trust Gap - Sanofi

A Million Conversations: Bridging Trust Gap  Sanofi

Sanofi Leans On AI And Rare Disease Detection To Shape Future Returns - Yahoo Finance

Sanofi Leans On AI And Rare Disease Detection To Shape Future Returns  Yahoo Finance

Amgen, Sanofi commit nearly $600M to North American expansions - BioSpace

Amgen, Sanofi commit nearly $600M to North American expansions  BioSpace

AI Across the R&D Value Chain: Portfolio Decision-Making - Sanofi

AI Across the R&D Value Chain: Portfolio Decision-Making  Sanofi

SANOFI : Deutsche Bank maintains a Buy rating - marketscreener.com

SANOFI : Deutsche Bank maintains a Buy rating  marketscreener.com

Sanofi scraps plan to develop next-generation mRNA seasonal flu vaccine - CIDRAP

Sanofi scraps plan to develop next-generation mRNA seasonal flu vaccine  CIDRAP

Sanofi granted Priority Review for Gaucher disease treatment - marketscreener.com

Sanofi granted Priority Review for Gaucher disease treatment  marketscreener.com

Sanofi defends Dupixent patents, but execs insist it has nothing to do with CEO change - BioSpace

Sanofi defends Dupixent patents, but execs insist it has nothing to do with CEO change  BioSpace

Texas sues Sanofi for allegedly 'bribing' providers to boost drug prescriptions - Reuters

Texas sues Sanofi for allegedly 'bribing' providers to boost drug prescriptions  Reuters

Garijo starts as Sanofi CEO with window to ease reliance on Dupixent - BioSpace

Garijo starts as Sanofi CEO with window to ease reliance on Dupixent  BioSpace

Sanofi and Pfizer get another conjugate blow | ApexOnco - Clinical Trials news and analysis - Onc...

Sanofi and Pfizer get another conjugate blow | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

Sanofi Officially Appoints Belén Garijo as Chief Executive Officer Following Shareholder Vote - P...

Sanofi Officially Appoints Belén Garijo as Chief Executive Officer Following Shareholder Vote  PharmExec.com

Sanofi Bets Up to $1.53B in Hong Kong Immuno Pact, Adding to String of Deals - BioSpace

Sanofi Bets Up to $1.53B in Hong Kong Immuno Pact, Adding to String of Deals  BioSpace

Sanofi posts upbeat sales as R&D pressure builds - BioPharma Dive

Sanofi posts upbeat sales as R&D pressure builds  BioPharma Dive

Sanofi immune drug hopeful posts mixed results in mid-stage tests - BioPharma Dive

Sanofi immune drug hopeful posts mixed results in mid-stage tests  BioPharma Dive

With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity - Fierce P...

With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity  Fierce Pharma

Sanofi Keeps Immuno Deals Coming With Kali Bet Worth Potential $1B+ - BioSpace

Sanofi Keeps Immuno Deals Coming With Kali Bet Worth Potential $1B+  BioSpace

Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees - Reuters

Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees  Reuters

Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike -...

Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike  Fierce Pharma

Sanofi MS drug rejected in US gets an endorsement in Europe - BioPharma Dive

Sanofi MS drug rejected in US gets an endorsement in Europe  BioPharma Dive

Sanofi’s bispecific scores double respiratory phase 2 wins, but flunks eczema study - Fierce Biotech

Sanofi’s bispecific scores double respiratory phase 2 wins, but flunks eczema study  Fierce Biotech

Sanofi Moves Away From mRNA Flu Vaccine as CEO Projects Confidence - BioSpace

Sanofi Moves Away From mRNA Flu Vaccine as CEO Projects Confidence  BioSpace

New NAACP, Sanofi Report Unveils Roadmap for Advancing Health Equity Across the Country - NAACP

New NAACP, Sanofi Report Unveils Roadmap for Advancing Health Equity Across the Country  NAACP

Sanofi returns to T-cell engager territory with $1.2B pact for phase 1-stage trispecific - Fierce...

Sanofi returns to T-cell engager territory with $1.2B pact for phase 1-stage trispecific  Fierce Biotech

Sanofi's solid earnings set stage for new CEO after drug trial 'setbacks' - Reuters

Sanofi's solid earnings set stage for new CEO after drug trial 'setbacks'  Reuters

Sanofi announces leadership evolution in Specialty Care Business Unit - Yahoo Finance

Sanofi announces leadership evolution in Specialty Care Business Unit  Yahoo Finance

Sanofi expects vaccine sales growth to dip amid ‘challenging environment’ - BioPharma Dive

Sanofi expects vaccine sales growth to dip amid ‘challenging environment’  BioPharma Dive

Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval - Fi...

Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval  Fierce Pharma

Backed by Sanofi, Pfizer, Earendil Bags $787M for AI-Driven Biologics Design - BioSpace

Backed by Sanofi, Pfizer, Earendil Bags $787M for AI-Driven Biologics Design  BioSpace

Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off - BioSpace

Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off  BioSpace

Is Sanofi SA (SNY) One of the Best Cheap Stocks to Buy for 2026 - Yahoo Finance

Is Sanofi SA (SNY) One of the Best Cheap Stocks to Buy for 2026  Yahoo Finance

Sanofi backs 2 more films about rare blood disorders - Fierce Pharma

Sanofi backs 2 more films about rare blood disorders  Fierce Pharma

Sanofi eczema drug weighed down by mixed results, safety concerns - BioPharma Dive

Sanofi eczema drug weighed down by mixed results, safety concerns  BioPharma Dive

Sanofi vaccine sales face headwinds from US policy shifts - Reuters

Sanofi vaccine sales face headwinds from US policy shifts  Reuters

Does Sanofi’s CEO Overhaul And Governance Shift Change The Bull Case For Sanofi (ENXTPA:SAN)? - Y...

Does Sanofi’s CEO Overhaul And Governance Shift Change The Bull Case For Sanofi (ENXTPA:SAN)?  Yahoo Finance

What Sanofi’s multiple sclerosis troubles could mean for the space - BioPharma Dive

What Sanofi’s multiple sclerosis troubles could mean for the space  BioPharma Dive

Sanofi Tops Q1 Earnings Estimates as Dupixent & New Drugs Drive Growth - Yahoo Finance

Sanofi Tops Q1 Earnings Estimates as Dupixent & New Drugs Drive Growth  Yahoo Finance

Four Penn State researchers receive iDEA-TECH awards from Sanofi - The Pennsylvania State University

Four Penn State researchers receive iDEA-TECH awards from Sanofi  The Pennsylvania State University

Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment - Reuters

Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment  Reuters

Sanofi Oncology And Rare Disease Updates Spark Fresh Valuation Interest - Yahoo Finance

Sanofi Oncology And Rare Disease Updates Spark Fresh Valuation Interest  Yahoo Finance

Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo - BioPharma Dive

Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo  BioPharma Dive

Sanofi Shares Decline as Paul Hudson Removed as CEO, Making Way For Merck KGaA’s Belén Garijo - B...

Sanofi Shares Decline as Paul Hudson Removed as CEO, Making Way For Merck KGaA’s Belén Garijo  BioSpace

Spurned by Sanofi, Orano turns to Roche | ApexOnco - Clinical Trials news and analysis - Oncology...

Spurned by Sanofi, Orano turns to Roche | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

Sanofi strikes deal with Brazil's EMS to sell generics manufacturer Medley - Fierce Pharma

Sanofi strikes deal with Brazil's EMS to sell generics manufacturer Medley  Fierce Pharma

With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine -...

With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine  Fierce Pharma

JPM26: With pricing deal in the books, Sanofi steels against lingering policy unknowns - Fierce B...

JPM26: With pricing deal in the books, Sanofi steels against lingering policy unknowns  Fierce Biotech

Sanofi sanctioned by PMCPA over CEO's 'bold claims' about Pfizer RSV vaccine - Fierce Pharma

Sanofi sanctioned by PMCPA over CEO's 'bold claims' about Pfizer RSV vaccine  Fierce Pharma

Sanofi launches innovation and operation centre in China - Reuters

Sanofi launches innovation and operation centre in China  Reuters

As its immunology work draws attention, Sanofi also pushes forward in rare disease - statnews.com

As its immunology work draws attention, Sanofi also pushes forward in rare disease  statnews.com

Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln - Reuters

Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln  Reuters

Sanofi Appoints Belén Garijo as CEO | PharmExec - PharmExec.com

Sanofi Appoints Belén Garijo as CEO | PharmExec  PharmExec.com

AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases - BioSpace

AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases  BioSpace

Sanofi’s Dupixent Win And New CEO Focus Attention On Execution - Yahoo Finance

Sanofi’s Dupixent Win And New CEO Focus Attention On Execution  Yahoo Finance

Paul Hudson out as Sanofi CEO - statnews.com

Paul Hudson out as Sanofi CEO  statnews.com

Sanofi to seek approval of touted eczema drug despite mixed results - BioPharma Dive

Sanofi to seek approval of touted eczema drug despite mixed results  BioPharma Dive

Sanofi's genetic disorder drug shows mixed results in late-stage trials - Reuters

Sanofi's genetic disorder drug shows mixed results in late-stage trials  Reuters

EU regulator backs Sanofi's injectable version of blood cancer drug - Reuters

EU regulator backs Sanofi's injectable version of blood cancer drug  Reuters

Sanofi Suffers Another Sales Dip for ‘Gift to Public Health’ Vaccines - BioSpace

Sanofi Suffers Another Sales Dip for ‘Gift to Public Health’ Vaccines  BioSpace

FDA Grants Breakthrough Therapy Designation to Venglustat in the US, Sanofi (SNY) Reports - Yahoo...

FDA Grants Breakthrough Therapy Designation to Venglustat in the US, Sanofi (SNY) Reports  Yahoo Finance

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer - Reuters

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer  Reuters

Sanofi CFO defends Hudson’s Dupixent legacy, but accepts ‘number of setbacks’ in R&D - Fierce Bio...

Sanofi CFO defends Hudson’s Dupixent legacy, but accepts ‘number of setbacks’ in R&D  Fierce Biotech

Press Release: Sanofi successfully prices 2.3 billion of bond issue - Yahoo Finance

Press Release: Sanofi successfully prices 2.3 billion of bond issue  Yahoo Finance

Sanofi SA (SNY) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... - Yahoo F...

Sanofi SA (SNY) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ...  Yahoo Finance

Blackstone puts $400M into Teva, Sanofi gut disease drug - BioPharma Dive

Blackstone puts $400M into Teva, Sanofi gut disease drug  BioPharma Dive

Sanofi abandons attempt to develop next-gen mRNA seasonal flu vaccine - Fierce Biotech

Sanofi abandons attempt to develop next-gen mRNA seasonal flu vaccine  Fierce Biotech

Sanofi keeps mum on future of disappointing Denali pact after scrapping final RIPK1 inhibitor - F...

Sanofi keeps mum on future of disappointing Denali pact after scrapping final RIPK1 inhibitor  Fierce Biotech

Sanofi points to 'key opportunity' for Teva-partnered IBD in long-term data - Fierce Biotech

Sanofi points to 'key opportunity' for Teva-partnered IBD in long-term data  Fierce Biotech

Sanofi's vaccine ambitions unfazed by 'politics or sentiment in the now,' CEO Paul Hudson says - ...

Sanofi's vaccine ambitions unfazed by 'politics or sentiment in the now,' CEO Paul Hudson says  Fierce Pharma

Sanofi steps back from radioconjugates | ApexOnco - Clinical Trials news and analysis - Oncology ...

Sanofi steps back from radioconjugates | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher...

Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease  The Manila Times

Sanofi- Cell Research outstanding paper award of 2024 - Nature

Sanofi- Cell Research outstanding paper award of 2024  Nature

Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes i...

Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children  Yahoo Finance

Is It Time To Reconsider Sanofi (ENXTPA:SAN) After Recent Share Price Weakness? - Yahoo Finance

Is It Time To Reconsider Sanofi (ENXTPA:SAN) After Recent Share Price Weakness?  Yahoo Finance

Modulus: Redefining the Future of Biopharma Manufacturing - Sanofi

Modulus: Redefining the Future of Biopharma Manufacturing  Sanofi

Sanofi becomes latest pharma to hold fire on UK R&D investments as funding fallout continues - Fi...

Sanofi becomes latest pharma to hold fire on UK R&D investments as funding fallout continues  Fierce Biotech

Amgen and Sanofi end epic battle over Praluent and Repatha - JUVE Patent

Amgen and Sanofi end epic battle over Praluent and Repatha  JUVE Patent